|
 |
|
2016 World CA Tumor Markers Testing Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
 |
|
$5450.00 |
| |
|
|
|
2016 World Pap Smear/HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$5450.00 |
| |
|
|
|
CA Tumor Markers: CA 15-3/27.29, CA 19-9, CA 125--US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$5450.00 |
| |
|
|
|
Pap Smear/Human Papillomavirus (HPV): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$5450.00 |
| |
|
|
|
Italy Cancer Diagnostics Market: Innovative Technologies and Emerging Business Opportunities
This report contains 570 pages, 83 tables and presents a comprehensive analysis of the Italian cancer diagnostics market, including:
|
|
|
$5400.00 |
| |
|
|
|
2016 World Cell Surface Markers Testing Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies....
|
|
|
$5350.00 |
| |
|
|
|
2014-2018 Global Cell Surface Markers Testing Market: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies....
|
|
|
$5350.00 |
| |
|
|
|
Triple Analysis: Breast Cancer, Leukemia and Melanoma
This triple analysis focuses on cancer drug development strategies in Breast Cancer, Leukemia and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology....
|
|
|
$5175.00 |
| |
|
|
|
Innovative CA Tumor Marker Testing Technologies and Emerging Markets
This report contains 278 pages, 40 tables and presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
|
|
|
$4850.00 |
| |
|
|
|
2014 Analysis of CA Tumor Marker Testing Technologies
and Emerging Markets
This report contains 278 pages, 40 tables and presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers....
|
|
|
$4850.00 |
| |
|
|
|
2014 Analysis of the Japanese Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including:Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$4850.00 |
| |
|
|
|
2015 Japanese Hospital Cancer Diagnostics Market
This new report from VPGMarketResearch.com contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including:
|
|
|
$4850.00 |
| |
|
|
|
CA Tumor Marker Testing Technologies and Emerging Markets 2014
This report contains 278 pages, 40 tables and presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers....
|
|
|
$4850.00 |
| |
|
|
|
Japanese Hospital Cancer Diagnostics Market 2014
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$4850.00 |
| |
|
|
|
2015 Japan Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review
This new report from VPGMarketResearch.com's contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including:
|
|
|
$4850.00 |
| |
|
|
|
2016 Australia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
2016 Austria Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
2016 Belgium Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
|